ABSTRACT -Rats were orally fed with different doses viz. 9.6, 12 and 15mg/kg/d from GD 0-20 and examined for evidence of fetotoxicity and teratogenecity to evaluate the potential effects of technical chlorpyrifos (97%). Fetotoxic effects were not observed at tested dose levels as evidenced by number of implantations, number of corpora lutea and live fetuses/dam, but significant alterations were noted in percent δ resorption and fetal weight. There were no major malformations, but some minor anomalies such as reduced parietal ossification and absence of phalanges found significant in high dose were not considered as compound-related effects. On the other hand the accumulation of chlorpyrifos residue in dams was more in brain (0.0328 μg/g) than in liver (0.0071 μg/g).The level of residue in fetuses was in the following order : liver (0.0531 μg/g) > brain (0.0364 μg/g) >placenta (0.040 μg/g) > amniotic fluid (0.0010 μg/g). Although, the total residue was higher in fetuses (0.0447 μg/g) than in dams (0.0120 μg/g), the absence of abnormalities in fetal gross morphology, visceral and skeleton suggest that technical chlorpyrifos at tested dose levels is non-teratogenic in rats.
INTRODUCTION
There is increasing concern about the organ distribution of organophosphate insecticides, especially chlorpyrifos, during developmental process. Chlorpyrifos acts as an irreversible inhibitor of acetylcholinesterase (AChE) in animals (Skai, 1991; Gordon et al., 1997) . Although chlorpyrifos is maternally acute toxic following oral exposure (McCollister et al., 1974; Tomlin, 1997) , in several studies it has shown as nonmutagenic, non-carcinogenic or non-teratogenic in animal species (Gibson et al., 1998; Hoberman, 1998) . While the AChE is believed to be one of the most sensitive parameters for organophosphate insecticides, the presence of chlorpyrifos residue in the umbilical cord and its association with decreased fetal growth among women during pregnancy raises question on the sensitivity of residue parameter (Whyatt et al., 2004) . Further more, it has been emphasized that prenatal exposure of women to chlorpyrifos would lead to shortening of the gestation period (Eskenazi et al., 2004) .Though chlorpyrifos is known to pose risk among children (USEPA, 2000) , it is still one of the most extensively used global insecticides (Levin, 2001) , against a variety of crop pests and termites (Aurthur,1995; Tomlin, 1997) . Development of an organism is a dynamic process characterized by change in size, biochemistry and physiology (Roger and Kevlock, 2001) ; exposure of chemicals during this period may produce abnormalities in fetal development. In spite of several reports indicating the non-teratogenicity of chlorpyrifos in animals, the present study has been designed to observe the fetotoxic effects and to correlate the changes with the amount of residue present in fetal tissues (transplacental disposition).
MATERIALS AND METHODS

Chemical
Technical chlorpyrifos (97%) was obtained as a gift from DE-NOCIL Crop Protection PVT Ltd., Noida, India.
Experimental design
Male and female rats (Rattus norvigicus, Wistar strain) of Industrial Toxicology Research Center's animal house were used for the experiment. A clearance from animal ethical committee of the institute was obtained for the use of animals (ITRC/IAEC/22/2005). Animals were maintained in a temperature (22 ± 3°C) and humidity (30-70%) controlled animal house with 12:12 hr light: dark cycle. Animals were given a synthetic pellet diet (Lipton India Ltd., India) and water ad libitum. Rats were acclimatized for one week prior to the experimentation. Adult virgin females, 190-200 g were mated with proven fertile males in 3:1 ratio in polypropylene cages overnight. Females were checked daily and on the day in which sperm were found in a veginal smear was considered as Day 0 of gestation. Eighty pregnant of the rats thus obtained were divided into four groups of twenty animals each.
Exposure of rats to chlorpyrifos
Three doses of technical chlorpyrifos (9.6, 12 and 15mg/kg/d) were suspended in corn oil and administered orally through gavage to pregnant rats from gestation day (GD) 0-20. Control animals were given corn oil (0.4ml/rat) in a similar fashion. The general condition and behavior of animals were observed once daily to access the pharmacotoxic symptoms. Body weight was monitored on Days 0, 6, 15, 20 of gestation. Food consumption was determined during the three consecutive periods (Days 0-6, 7-15and 16-20) of gestation.
Treated and control dams were euthenised and decapitated on Day 21 of gestation. Uteri were removed by caesarean section and implantation sites were examined by placing the uterine horn of individual animals in 10% ammonium sulfide solution (Kop et al., 1964) for 15 min. The fetuses were removed from the uterus, dried of amniotic fluid, weighed, sexed by observing the anogenital distance and examined under a dissecting microscope for external anomalies (Taylor, 1986) .Early and late resorption and dead fetuses were counted. One-half of the total fetuses from each group were fixed in 95% ethanol for 4 days. The dehydrated, eviscerated and partially skinned fetuses were placed in 1% KOH solution to remove the non-calciferous tissues and stained with Alizarin Red S (Staples and Schnell, 1964) for skeletal examination (Kelsey, 1974; Taylor, 1986) .The remaining fetuses were preserved in Bouin's fluid for evaluation of visceral abnormalities (Wilson, 1965) . The tissues (liver and brain) for chlorpyrifos residues were obtained from the same fetuses which were examined for visceral abnormalities.
Detailed morphological, visceral and skeletal examinations were conducted on fetuses of all groups.
Residue analysis
Liver, brain of dams and fetuses along with placenta and amniotic fluid collected by puncturing the amniotic sac were subjected for extraction and cleanup for residue analysis of chlorpyrifos (Lino and Silveira, 1994) . The chlorpyrifos was determined by Gas Chromatography NUCON model 5765 using electron capture detector (ECD) with the following conditions: detector temperature 250°C, injector temperature 250°C and column temperature 190°C, with N 2 gas flow rate 60 ml/min.
Statistical analysis
Statistical comparisons were made using nonparametric ANOVA and parameters were compared at 5% level of significance (Siegel, 1956 ). However, the incidences of percent resorption, sex ratio, and percentage of skeletal abnormalities were calculated by Chi-square test (Snedecor and Cocharan, 1967) .
RESULTS
Maternal observations
Dams administered different doses of chlorpyrifos (9.6, 12, 15 mg/kg/d) from GD 0-20 and showed signs of toxicity such as tremor, eye and nose bleeding only at the 15 mg/kg/d dose level (Table 1) . However, no toxic symptoms were observed in animals exposed to other dose levels (9.6 and 12 mg/kg/d). Rats exposed to high dose (15 mg/kd/d) of chlorpyrifos consumed significantly less food on the first week of dosing, but was in significant in the second and third weeks (Table  2) . There was no change in feed consumption of rats exposed to lower doses of chlorpyrifos (9.6 and 12 mg/ kg/d). A significant decrease in body weight gain was observed in dams exposed to chlorpyrifos at 12 and 15 mg/kg/d dose levels (Table 3) .
Reproductive performance
There was an apparent decrease in the number of corpora lutea, implantations and live fetuses of dams orally administered a high dose (15 mg/kg/d) of chlorpyrifos, but this was statistically insignificant. However, there was a significant decrease in fetal weight of dams exposed to a high dose of chlorpyrifos. The sex ratio of male and female fetuses of treated dams was comparable to the respective fetuses of controls. A significant increase in the percent δ resorption was observed in dams treated with 12 and 15 mg/kg/d of chlorpyrifos (Table 4) .
Fetal observations 1. Morphological observations
The detailed morphological observations of fetuses are shown in Table 5 . Ectrodactyly, hydrocephaly, kinky tail and scoliosis were externally visible anomalies found in a few fetuses of treated and control dams. However, the incidences of these anomalies were not statistically significant as compared to controls.
Visceral observations
None of the fetuses showed major visceral malfo r m atio n s . F ew v is c er al an om a lies s uc h as hydroureter and adrenal hydrocephaly were present in two or three fetuses of the treated and control dams. However, the visceral anomalies were not statistically significant and none of the anomalies was considered to be treatment-related (Table 5) .
Skeletal observation
In general, the skeletons of all the fetuses were normal in appearance, but a few fetuses showed significantly reduced parietal ossification (1-7.8%) and absence of phalanges (1-7.8%) in dams exposed to the high dose (15 mg/kg/d) of chlorpyrifos (Table 5 ).
Residue analysis
Significant dose response relationship in dam brain was observed (p<0.05). However, in the liver no such trend with increasing dose was observed. In fetuses the mean value of the residues in the brain were Table 1 . Incidence of symptoms in dams (20 Nos) orally exposed to chlorpyrifos from GD 0-20. Table 2 . Food intake* of dams (g/day) orally exposed to chlorpyrifos from GD 0-20. Table 3 . Body weight* gain of dams orally exposed to chlorpyrifos from GD 0-20. In reference to dose mean residue of dam's brain at 12 and 15mg/kg/d dose levels were statistically higher (p<0.01) in comparison to the mean residues in liver. Overall mean residues of fetuses in liver were higher as compared to brain, but the difference was not statistically significant at the lower doses (9.6 and 12 mg/kg/d). However mean residues in liver were statistically higher (p<0.01) at 15 mg/kg/d dose.
Total brain residues (all concentrations together) in dams were statistically higher (p<0.05) as compared to liver. However total residues in liver tissue in fetuses were significantly higher (p<0.05) as compared to the brain. Overall, the mean values of tissues (brain +liver) of all concentrations in fetuses were significantly higher (p<0.05) as compared to dams. The disposition trend in fetuses was liver>brain>placenta>amniotic fluid and in dams brain>liver. There were no residues of chlorpyrifos in the above tissues of control dams and their fetuses (Table 6) .
DISCUSSION
In the present transplacental disposition and teratogenecity study, administration of chlorpyrifos to pregnant rats by oral gavage, resulted in significant maternal effects that included tremor, nose and eye bleeding and low body weight gain at highest dose, i.e. 15 mg/kg/d. The study supports the finding of several authors (Lachner and Abdel-Rehman, 1984; Clemens et al., 1990; Leborde et al., 1996 and Farag et al., 2000) . These studies suggest that doses which are not maternally toxic (symptoms appeared but no death occurred) were unable to produce fetotoxicity or teratogenicity. The results postulated that fetotoxic/teratogenic effects of chlorpyrifos were not attributed to maternal toxicity, which is in contrast to other published reports (Machin and Bride, 1984; Ballantyne and Marrs, 1992) . Chlorpyrifos exposure to pregnant animals has been reported to migrate transplacentally, thereby causing neurotoxic symptoms during fetal development (Barone et al., 2000; Pope ,1999; Slotkin,2000) . The amount of chlorpyrifos residue present in the fetal brain and liver indicates that organophosphate pesticides have crossed over to the fetus through the placenta. Mattsson et al. (1998) have also reported an appreciable amount of chlorpyrifos residue in the fetal blood of dams exposed during pregnancy. The accumulation of residue in placenta and amniotic fluid in the present study was less than in fetal liver and brain. It is obvious (Lassiter et al., 1998 ) that two of the enzymes known to detoxify chlorpyrifos were either not enriched (chlorpyrifos-oxonase) or only slightly enriched (carboxylesterase; ≤ 35%) in placental tissue, indicating that placenta may not be a preferential site for a chlorpyrifos metabolism which would protect the fetus. This may be reason for low retention of chlorpyrifos in placenta and amniotic fluid and disposition of chlorpyrifos to fetal tissue. Fetotoxic/teratogenic effects are manifested by the presence of increased resorption, skeletal malformations and loss of fetal weight caused by the candidate compound. In the present study, high dose (15 mg/kg/d) of chlorpyrifos also induced fetal death and minor insignificant malformations. Similar observations in rats exposed to chlorpyrifos at 15 mg/kg/d dose were also reported (Breslin et al., 1996; Farag et al., 2003) . Transfer and compartmentalization of chemical from mother to Table 5 . Morphological, visceral and skeletal observations of fetuses of dams orally exposed to chlorpyrifos from GD 0-20. fetus through placenta is an important factor for determining fetal resorption (Nau and Scott, 1985) . Percent decrease in the body weight gain of dams and fetal weight loss have been found to be associated with fetal resorptions. A few statistically insignificant morphological and skeletal variations were observed at the highest tested dose of chlorpyrifos in the present study. Earlier several authors (Decon et al., 1980; Chahoud et al., 1999; Tian et al., 2005) have reported similar findings using various doses of chlorpyrifos (including maternal toxic dose) including few incidences of malformations in species of animals. Absences of significant morphological, visceral and skeletal malformations in the present study indicate the non-teratogenic effect of chlorpyrifos at 15 mg/kg/d dose level. Eriksson et al. (1973) advocated that cumulative chemical exposure of fetus is more important than the rate of chemical transfer. Although, in the present study, an appreciable amounts of chlorpyrifos residues were detected in different vital organs of the fetal tissues failed to produce any morphological, visceral or skeletal abnormalities. These findings raise the concern about possible impaired fetal development following transmigration of chlorpyrifos. Hence, it is presumed that comparison of chlorpyrifos residues in different maternal and fetal tissues unlikely suggest that the residue level only may not be found to produce morphological, visceral, and skeletal abnormalities in rats.
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